FDA inspection
ScieGen Pharmaceuticals India Private Limited: FDA inspection ending Nov 7, 2025
FDA inspection 1294366 · No Action Indicated (NAI) · Jadcherla
Key facts
| Inspection ID | 1294366 |
|---|---|
| Firm | ScieGen Pharmaceuticals India Private Limited |
| FEI number | 3032546867 |
| Address | Plot No 10 - 14, Sy No 408 - 412 - 418 - 434; Gip |
| City | Jadcherla |
| Fiscal year | 2026 |
| Inspection end date | Nov 7, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data